Mostrar el registro sencillo del ítem

dc.contributor.authorGómez-Morón, Álvaro
dc.contributor.authorRequena, Silvia
dc.contributor.authorPertusa, Clara
dc.contributor.authorLozano-Prieto, Marta
dc.contributor.authorCalzada-Fraile, Diego
dc.contributor.authorScagnetti, Camila
dc.contributor.authorSánchez-García, Inés
dc.contributor.authorCalero-García, Ana Adela
dc.contributor.authorIzquierdo, Manuel
dc.contributor.authorMartín-Cófreces, Noa B
dc.date.accessioned2023-09-05T08:14:05Z
dc.date.available2023-09-05T08:14:05Z
dc.date.issued2023
dc.identifier.citationFront Immunol. 2023 Jul 13;14:1197289.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16404
dc.description.abstractThe organization of the mitochondrial network is relevant for the metabolic fate of T cells and their ability to respond to TCR stimulation. This arrangement depends on cytoskeleton dynamics in response to TCR and CD28 activation, which allows the polarization of the mitochondria through their change in shape, and their movement along the microtubules towards the immune synapse. This work focus on the role of End-binding protein 1 (EB1), a protein that regulates tubulin polymerization and has been previously identified as a regulator of intracellular transport of CD3-enriched vesicles. EB1-interferred cells showed defective intracellular organization and metabolic strength in activated T cells, pointing to a relevant connection of the cytoskeleton and metabolism in response to TCR stimulation, which leads to increased AICD. By unifying the organization of the tubulin cytoskeleton and mitochondria during CD4+ T cell activation, this work highlights the importance of this connection for critical cell asymmetry together with metabolic functions such as glycolysis, mitochondria respiration, and cell viability.es_ES
dc.description.sponsorshipThis study was supported by grants S2022/BMD-7209- INTEGRAMUNE-CM to NBMC from the Madrid Regional Government, PDC2021-121719-I00 and PLEC2022-009298 (AEI/ FEDER, UE) from the Spanish Ministry of Economy and Competitiveness (MINECO). Work in the MI lab is funded by grant PID2020-114148RB-I00 from the Spanish Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033, which was in part granted with FEDER funding (EC). CIBER Cardiovascular (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional FEDER). ÁG-M is supported by an Investigo Grant by SEPE (Fondos de Resiliencia), Gobierno de España. SR is supported by a Sara Borrell fellowship from ISCIII and DC-F is supported by a fellowship from “la Caixa” Foundation (LCF/BQ/DR19/11740010). CS is supported by PEJ-2021-TL/BMD-21204 “Garantı́ a Juvenil” grant form Comunidad de Madrid. ML-P is a FPI fellowship (PRE2021- 097478) from the Spanish Ministry of Science and Innovation. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the ISCIII, the Ministerio de Ciencia e Innovación and the Pro CNIC Foundation. The CNIC is a Severo Ochoa Center of Excellence (MINECO award CEX2020-001041-S). Funding agencies have not intervened in the design of the studies, with no copyright over the study.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Media es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshMicrotubule-Associated Proteins es_ES
dc.subject.meshCD4-Positive T-Lymphocytes es_ES
dc.subject.meshMitochondria es_ES
dc.subject.meshJurkat Cells es_ES
dc.subject.meshHumans es_ES
dc.subject.meshTubulin es_ES
dc.subject.meshCytoskeleton es_ES
dc.subject.meshReceptors, Antigen, T-Celles_ES
dc.subject.meshCD28 Antigens es_ES
dc.subject.meshMembrane Potential, Mitochondriales_ES
dc.subject.meshImmunological Synapses es_ES
dc.titleEnd-binding protein 1 regulates the metabolic fate of CD4+ T lymphoblasts and Jurkat T cells and the organization of the mitochondrial network.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID37520527es_ES
dc.format.volume14es_ES
dc.format.page1197289es_ES
dc.identifier.doi10.3389/fimmu.2023.1197289es_ES
dc.contributor.funderComunidad de Madrid (España) es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España) es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderFundación La Caixa es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) es_ES
dc.contributor.funderFundación ProCNIC es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1664-3224es_ES
dc.relation.publisherversion10.3389/fimmu.2023.1197289es_ES
dc.identifier.journalFrontiers in immunologyes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Comunicación Intercelular en la Respuesta Inflamatoriaes_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/S2022/BMD-7209-INTEGRAMUNE-CMes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PDC2021-121719-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PLEC2022-009298es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2020-114148RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MCIN/AEI/ 10.13039/501100011033es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/BQ/DR19/11740010es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PEJ-2021-TL/BMD-21204es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PRE2021-097478es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CEX2020-001041-Ses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional